Rare disease clinical trials: FDA awards $15M in grants
After receiving 89 clinical trial grant applications, the FDA on Tuesday selected 12 projects that will be funded with more than $15 million over the next four years.
The announcement of the new funding comes as approximately 30 million Americans are affected by 7,000 known rare diseases, but only a few hundred treatments exist for these rare diseases.
Two-thirds of the 2019 grants will go to studies affiliated with universities, two-thirds will also go for studies of rare cancers and three-quarters of the new awards fund studies enrolling children, including children as young as one month, according to the FDA.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.